375 related articles for article (PubMed ID: 22688083)
21. Gefitinib in patients with progressive high-grade gliomas: a multicentre phase II study by Gruppo Italiano Cooperativo di Neuro-Oncologia (GICNO).
Franceschi E; Cavallo G; Lonardi S; Magrini E; Tosoni A; Grosso D; Scopece L; Blatt V; Urbini B; Pession A; Tallini G; Crinò L; Brandes AA
Br J Cancer; 2007 Apr; 96(7):1047-51. PubMed ID: 17353924
[TBL] [Abstract][Full Text] [Related]
22. Phase II trial of patupilone in patients with brain metastases from breast cancer.
Peereboom DM; Murphy C; Ahluwalia MS; Conlin A; Eichler A; Van Poznak C; Baar J; Elson P; Seidman AD
Neuro Oncol; 2014 Apr; 16(4):579-83. PubMed ID: 24470546
[TBL] [Abstract][Full Text] [Related]
23. Response patterns of recurrent glioblastomas treated with tumor-treating fields.
Vymazal J; Wong ET
Semin Oncol; 2014 Oct; 41 Suppl 6():S14-24. PubMed ID: 25213870
[TBL] [Abstract][Full Text] [Related]
24. Phase II trial of weekly patupilone in patients with castration-resistant prostate cancer.
Hussain A; DiPaola RS; Baron AD; Higano CS; Tchekmedyian NS; Johri AR
Ann Oncol; 2009 Mar; 20(3):492-7. PubMed ID: 19087985
[TBL] [Abstract][Full Text] [Related]
25. Epothilone B inhibits migration of glioblastoma cells by inducing microtubule catastrophes and affecting EB1 accumulation at microtubule plus ends.
Pagano A; Honoré S; Mohan R; Berges R; Akhmanova A; Braguer D
Biochem Pharmacol; 2012 Aug; 84(4):432-43. PubMed ID: 22634050
[TBL] [Abstract][Full Text] [Related]
26. Patupilone in patients with pretreated metastatic/locally recurrent colorectal cancer: results of the Phase II CINATRA trial.
Moorcraft SY; Chau I; Peckitt C; Cunningham D; Rao S; Yim KL; Walther A; Jackson CG; Stamp G; Webb J; Smith G; Gillbanks A; Swanton C
Invest New Drugs; 2013 Oct; 31(5):1339-44. PubMed ID: 23801302
[TBL] [Abstract][Full Text] [Related]
27. Clinical activity and safety of atezolizumab in patients with recurrent glioblastoma.
Lukas RV; Rodon J; Becker K; Wong ET; Shih K; Touat M; Fassò M; Osborne S; Molinero L; O'Hear C; Grossman W; Baehring J
J Neurooncol; 2018 Nov; 140(2):317-328. PubMed ID: 30073642
[TBL] [Abstract][Full Text] [Related]
28. Multiple microsurgical resections for repeated recurrence of glioblastoma multiforme.
Hong B; Wiese B; Bremer M; Heissler HE; Heidenreich F; Krauss JK; Nakamura M
Am J Clin Oncol; 2013 Jun; 36(3):261-8. PubMed ID: 22495452
[TBL] [Abstract][Full Text] [Related]
29. Phase II trial of tipifarnib in patients with recurrent malignant glioma either receiving or not receiving enzyme-inducing antiepileptic drugs: a North American Brain Tumor Consortium Study.
Cloughesy TF; Wen PY; Robins HI; Chang SM; Groves MD; Fink KL; Junck L; Schiff D; Abrey L; Gilbert MR; Lieberman F; Kuhn J; DeAngelis LM; Mehta M; Raizer JJ; Yung WK; Aldape K; Wright J; Lamborn KR; Prados MD
J Clin Oncol; 2006 Aug; 24(22):3651-6. PubMed ID: 16877733
[TBL] [Abstract][Full Text] [Related]
30. A phase II trial of erlotinib in patients with recurrent malignant gliomas and nonprogressive glioblastoma multiforme postradiation therapy.
Raizer JJ; Abrey LE; Lassman AB; Chang SM; Lamborn KR; Kuhn JG; Yung WK; Gilbert MR; Aldape KA; Wen PY; Fine HA; Mehta M; Deangelis LM; Lieberman F; Cloughesy TF; Robins HI; Dancey J; Prados MD;
Neuro Oncol; 2010 Jan; 12(1):95-103. PubMed ID: 20150372
[TBL] [Abstract][Full Text] [Related]
31. Phase II study of MEDI-575, an anti-platelet-derived growth factor-α antibody, in patients with recurrent glioblastoma.
Phuphanich S; Raizer J; Chamberlain M; Canelos P; Narwal R; Hong S; Miday R; Nade M; Laubscher K
J Neurooncol; 2017 Jan; 131(1):185-191. PubMed ID: 27844311
[TBL] [Abstract][Full Text] [Related]
32. The relationship between six-month progression-free survival and 12-month overall survival end points for phase II trials in patients with glioblastoma multiforme.
Ballman KV; Buckner JC; Brown PD; Giannini C; Flynn PJ; LaPlant BR; Jaeckle KA
Neuro Oncol; 2007 Jan; 9(1):29-38. PubMed ID: 17108063
[TBL] [Abstract][Full Text] [Related]
33. Aggressive repeat surgery for focally recurrent primary glioblastoma: outcomes and theoretical framework.
Sughrue ME; Sheean T; Bonney PA; Maurer AJ; Teo C
Neurosurg Focus; 2015 Mar; 38(3):E11. PubMed ID: 25727220
[TBL] [Abstract][Full Text] [Related]
34. Clinical practice experience with NovoTTF-100A™ system for glioblastoma: The Patient Registry Dataset (PRiDe).
Mrugala MM; Engelhard HH; Dinh Tran D; Kew Y; Cavaliere R; Villano JL; Annenelie Bota D; Rudnick J; Love Sumrall A; Zhu JJ; Butowski N
Semin Oncol; 2014 Oct; 41 Suppl 6():S4-S13. PubMed ID: 25213869
[TBL] [Abstract][Full Text] [Related]
35. Open-Label Phase II Evaluation of Imatinib in Primary Inoperable or Incompletely Resected and Recurrent Glioblastoma.
Sautter L; Hofheinz R; Tuettenberg J; Grimm M; Vajkoczy P; Groden C; Schmieder K; Hochhaus A; Wenz F; Giordano FA
Oncology; 2020; 98(1):16-22. PubMed ID: 31514200
[TBL] [Abstract][Full Text] [Related]
36. Sorafenib for patients with pretreated recurrent or progressive high-grade glioma: a retrospective, single-institution study.
Hassler MR; Ackerl M; Flechl B; Sax C; Wöhrer A; Widhalm G; Dieckmann K; Hainfellner J; Preusser M; Marosi C
Anticancer Drugs; 2014 Jul; 25(6):723-8. PubMed ID: 24441743
[TBL] [Abstract][Full Text] [Related]
37. MR-guided laser-induced thermal therapy (LITT) for recurrent glioblastomas.
Carpentier A; Chauvet D; Reina V; Beccaria K; Leclerq D; McNichols RJ; Gowda A; Cornu P; Delattre JY
Lasers Surg Med; 2012 Jul; 44(5):361-8. PubMed ID: 22488658
[TBL] [Abstract][Full Text] [Related]
38. Epothilones in the treatment of ovarian cancer.
Diaz-Padilla I; Oza AM
Future Oncol; 2011 Apr; 7(4):559-68. PubMed ID: 21463144
[TBL] [Abstract][Full Text] [Related]
39. Neurosurgical management and prognosis of patients with glioblastoma that progresses during bevacizumab treatment.
Clark AJ; Lamborn KR; Butowski NA; Chang SM; Prados MD; Clarke JL; McDermott MW; Parsa AT; Berger MS; Aghi MK
Neurosurgery; 2012 Feb; 70(2):361-70. PubMed ID: 21841523
[TBL] [Abstract][Full Text] [Related]
40. A phase 2 trial of irinotecan (CPT-11) in patients with recurrent malignant glioma: a North American Brain Tumor Consortium study.
Prados MD; Lamborn K; Yung WK; Jaeckle K; Robins HI; Mehta M; Fine HA; Wen PY; Cloughesy T; Chang S; Nicholas MK; Schiff D; Greenberg H; Junck L; Fink K; Hess K; Kuhn J;
Neuro Oncol; 2006 Apr; 8(2):189-93. PubMed ID: 16533878
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]